These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 17360301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.
    Klubo-Gwiezdzinska J, Lange M, Cochran E, Semple RK, Gewert C, Brown RJ, Gorden P.
    Diabetes Care; 2018 Nov; 41(11):2353-2360. PubMed ID: 30201849
    [Abstract] [Full Text] [Related]

  • 5. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS, Johnson JL, Elliott-Mills D, Opas LM.
    Lupus; 1997 Nov; 6(3):275-8. PubMed ID: 9104736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
    Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW.
    Diabetes Care; 1998 Aug; 21(8):1217-20. PubMed ID: 9702422
    [Abstract] [Full Text] [Related]

  • 8. Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.
    el-Reshaid K, al-Mofti S, Stepic NR.
    Diabetes Res Clin Pract; 1994 Oct; 25(3):207-10. PubMed ID: 7851276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome.
    Osanami A, Kanda M, Sato T, Akazawa C, Baba S, Komatsu H, Murase K, Yamashita T, Yano T.
    Front Endocrinol (Lausanne); 2022 Oct; 13():997296. PubMed ID: 36157458
    [Abstract] [Full Text] [Related]

  • 13. Extreme insulin resistance due to anti-insulin receptor antibodies: a direct demonstration of autoantibody secretion by peripheral lymphocytes.
    Di Paolo S, Lattanzi V, Guastamacchia E, Vincenti C, Balice AM, Montanaro N, Nardelli GM, Giorgino R.
    Diabetes Res Clin Pract; 1990 Apr; 9(1):65-73. PubMed ID: 2190781
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review.
    Zhang S, Wang G, Wang J.
    Clin Rheumatol; 2013 Feb; 32(2):181-8. PubMed ID: 23053690
    [Abstract] [Full Text] [Related]

  • 18. Refractory hyperglycemia complicating an evolving connective tissue disease: response to cyclosporine.
    Kramer N, Rosenstein ED, Schneider G.
    J Rheumatol; 1998 Apr; 25(4):816-8. PubMed ID: 9558194
    [Abstract] [Full Text] [Related]

  • 19. A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin receptor antibodies.
    Kato Y, Ichiki Y, Kitajima Y.
    Rheumatol Int; 2008 Nov; 29(1):103-5. PubMed ID: 18500459
    [Abstract] [Full Text] [Related]

  • 20. A patient with type B insulin resistance syndrome, responsive to immune therapy.
    Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold KC, Inzucchi SE.
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):835-40. PubMed ID: 18026162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.